YZL-33534-17583
2 vaccinations
1 coded response
15 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 107 / NY
- Registered
- 2021-01-25
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-25
Registered in v-safe
-
2021-01-25
Dose 1 — Pfizer-BioNTech
- 2021-01-25
-
2021-01-26
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness, Nausea, Vomiting · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-26
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-28
- 2021-01-29
- 2021-02-04
- 2021-02-08
-
2021-02-15
Dose 2 — Pfizer-BioNTech
- 2021-02-15
-
2021-02-16
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, DiarrheaAdult check-in
-
2021-02-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body aches, DiarrheaAdult check-in
- 2021-02-19
- 2021-02-24
-
2021-03-02
Survey response — day 14, dose 2MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Severe headacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-10
- 2021-03-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-25 | Pfizer-BioNTech | |
| 2 | 2021-02-15 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-26 | priority 2/3 |
Free text
Release 4 — day 14, dose 2
Symptoms: Severe headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release